The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...

Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID-19 test, dubbed the Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects ...

Consult virtually and on-demand with a healthcare professional about their test result; Obtain an e-prescription - if medically indicated - for a medication to treat the virus; and Get the medication ...

SAN DIEGO, Oct. 6, 2022 /PRNewswire/ -- Cue Health Inc. (HLTH), a healthcare technology company, has partnered with actress Jamie-Lynn Sigler, the actress best known for her roles on The Sopranos and ...

The FDA granted emergency use authorization June 12 to healthcare tech company Cue Heath’s rapid COVID-19 test. The single-use molecular test identifies the RNA of the virus that causes COVID-19 from ...

Oct 13 (Reuters) - The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and ...

(RTTNews) - Healthcare technology company Cue Health (HLTH) announced Monday it has completed an analysis of the SARS-CoV-2 B.1.1.529 variant, designated by the World Health Organization as Omicron.

The free COVID-19 tests the federal government recently rolled out will expire soon, but there is an explanation for that. Two weeks ago, the U.S. Department of Health and Human Services announced ...

Add Yahoo as a preferred source to see more of our stories on Google. Covid-19 at home Rapid Test Kit The FDA has extended the shelf life for some COVID-19 tests. Now that allergy season is here, many ...

Update: This program has ended and free tests are not current available from the government website. As cases of a new COVID-19 variant tick upward across the U.S., the federal government is again ...